HIGHLIGHTS
- who: Tingxiao Zhao and colleagues from the State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Qingchun Rd, Hangzhou City, China have published the article: Comparing Long-Term Outcomes of Entecavir and Tenofovir Disoproxil Fumarate in Liver Transplant Patients, in the Journal: Advanced Gut and Microbiome Research of 19/Dec/2022
- what: The authors aimed to assess the association between TDF use and longterm outcome compared to recipients using ENT. The authors analyzed the long-term outcomes of 907 liver transplant recipients treated with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.